The H1N1 vaccines used in the 2021 swine flu pandemic viruses were designed to guard against the new pandemic H1N1 strain. These novel pandemic viruses were created using a virus strain that had never been investigated or detected before. There are no records of prior spontaneous H1N1 infections since no strain of H1N1 has ever created an epidemic. Because this is the first time this has happened, a lot of study and testing is still being done to assess the safety and efficacy of these new H1N1 vaccines. This H1N1 vaccine is still being developed and will be the first of its type.
The new swine flu vaccines are prepared in the same clinic that performs the regular seasonal flu shots, unlike the traditional seasonal flu vaccines, which are made in a lab and only after the required testing are done. The traditional seasonal flu vaccination, as well as the new one, are both manufactured from a live virus. As a result, it poses minimal or no risk to people with weakened immune systems. People with immune system deficits, on the other hand, may still be harmed by the new H1N1 vaccines. People whose immune systems have been substantially weakened by medical illnesses such as HIV/AIDS or cancer therapy fall into this category.
Read More: https://bit.ly/3jOg4EE
